Invasive Lobular Carcinoma of the Breast
📧 Sign up to get email alerts when something new happens for Invasive Lobular Carcinoma of the Breast.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Demographics, Characteristics and Outcomes of Male Breast Cancer Patients at Methodist Health System
This clinical trial update reports demographics, characteristics, and outcomes of male breast cancer patients treated at Methodist Health Sy…
-
CLINICAL_TRIALS trial_result · 2025-05-01Clinical Trial Update: Taletrectinib in Previously Treated Metastatic CDH1-mutated Invasive Lobular Cancer (ILC) [Phase 2]
A Phase 2 trial of Taletrectinib for previously treated metastatic CDH1-mutated invasive lobular breast cancer has been suspended.
-
CLINICAL_TRIALS trial_result · 2025-01-17Clinical Trial Update: Fluciclovine and PSMA PET/CT for the Classification and Improved Staging of Invasive Lobular Breast Cancer [Phase 1]
The Phase 1 trial evaluates fluciclovine and PSMA PET/CT for classification and improved staging of invasive lobular breast cancer. The stud…
-
CLINICAL_TRIALS trial_result · 2024-07-31Clinical Trial Update: Hypofractionated Image Guided Radiation Therapy in Treating Patients With Stage IV Breast Cancer
A clinical trial evaluated hypofractionated image-guided radiation therapy for patients with stage IV breast cancer. The study status is com…